Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127666801 | 12766680 | 1 | I | 20160909 | 20160921 | 20160921 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-124009 | RANBAXY | 58.00 | YR | F | Y | 64.86000 | KG | 20160921 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127666801 | 12766680 | 1 | PS | Atorvastatin | ATORVASTATIN | 1 | Oral | 20 MG, QD | Y | U | 2778927 | 76477 | 20 | MG | |||||
| 127666801 | 12766680 | 2 | C | BUDESONIDE. | BUDESONIDE | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127666801 | 12766680 | 1 | Blood cholesterol |
| 127666801 | 12766680 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127666801 | 12766680 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127666801 | 12766680 | Disturbance in attention | |
| 127666801 | 12766680 | Fatigue | |
| 127666801 | 12766680 | Nightmare |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127666801 | 12766680 | 1 | 20160805 | 20160823 | 0 |